Robert F. Friel's most recent trade in Xylem Inc was a trade of 1,851 Common Stock done at an average price of $126.9 . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xylem | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 126.93 per share. | 13 May 2025 | 1,851 | 36,031 (0%) | 0% | 126.9 | 234,947 | Common Stock |
| West Pharma Services | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 1,071 | 4,681 (0%) | 0% | 0 | Common Stock | |
| Xylem | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,647 | 33,926 (0%) | 0% | 0 | Common Stock | |
| West Pharma Services | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2024 | 564 | 3,610 (0%) | 0% | 0 | Common Stock | |
| Xylem | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,250 | 32,017 (0%) | 0% | 0 | Common Stock | |
| West Pharma Services | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 616 | 3,046 (0%) | 0% | - | Common Stock | |
| West Pharma Services | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 632 | 2,430 (0%) | 0% | - | Common Stock | |
| Xylem | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 2,627 | 29,538 (0%) | 0% | 0 | Common Stock | |
| Xylem | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 1,925 | 26,735 (0%) | 0% | 0 | Common Stock | |
| West Pharma Services | Robert F. Friel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 577 | 1,798 (0%) | 0% | - | Common Stock |